Broadcasts
Live at CPhi / ICSE - Almac’s key capital investments in US commercial packaging and non-gmp development
October 2012
David Downey, VP Commercial Operations, discusses this years contract pharmaceutical development and manufacturing outsourcing trends, highlighting Almac’s key capital investments in US commercial packaging and non-gmp development to meet growing client demands.
Click here to watch the interview featuring David Downey VP Commercial Operations
____________________________________________________________________________________________
PharmaVoice – Editors’s Take
26 July 2012
Thought Leader: Jim Murphy, President and Managing Director of Almac’s Clinical Technologies business unit discusses the best practices to running global clinical trials and how the advent of strategic outsourcing is impacting clinical supply management.
Click here to watch the interview featuring Jim Murphy, President and Managing Director (Almac’s Clinical Technologies business unit).
___________________________________________________________________________________________________________
Live From Interphex: Commercial Packaging Facility Coming To Pennsylvania
04 May 2012
Almac announces additional details on their new commercial packaging facility opening Fall 2012 in Audubon, Pennsylvania.
Click here to watch the interview featuring David Downey, VP Commercial Operations (Almac’s Pharma Services business unit).
___________________________________________________________________________________________________________
Almac Discusses Growing Demand for non-GMP Contracting on Outsourcing-Pharma
15 November 2011
Almac says growing demand for non-GMP manufacturing work rather than competition was the key driver for expansion of its product development services business.
Click here to listen to the interview featuring David Downey, VP Commercial Operations (Almac’s Pharma Services business unit).
___________________________________________________________________________________________________________
Almac Talks Expansion at Interphex 2011 on Outsourcing-Pharma
20 April 2011
Outsourcing-Pharma spoke with James McGibbon from Almac at Interphex 2011 in New York who cited the recent addition of biopharmaceuticals storage capacity at the global headquarters in Craigavon, Northern Ireland as an example of Almac’s recent growth.
Click here to watch the interview featuring James McGibbon, Director of Business Development (Almac’s Pharma Services business unit).
_________________________________________________________________________________________________
Almac Discusses its Investment in Biocatalysis Lauding Cost and Environmental Benefits on Outsourcing-Pharma
13 October 2010
Almac invests $4m in biocatalysis R&D, describing such technologies as the way forward for the cost efficient production of highly chiral APIs and intermediates.
Click here to listen to the podcast featuring Tom Moody, head of Almac’s biocatlaysis unit (Almac Sciences business unit).
___________________________________________________________________________________________________________
Almac Discusses New Biomarker Service on Outsourcing-Pharma
26th August 2010
Almac says an effective biomarker strategy boosts a drug candidates’ chance of success and can ultimately add value to a developer’s business by opening door to diagnostics.
Click here to listen to podcast featuring Michael Sloan, VP Business Development (Almac’s Diagnostics business unit).
